Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Decker

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
Pediatrics|September 1, 1995
Comparison of 13 acellular pertussis vaccines: overview and serologic responseK M Edwards, B D Meade, M D Decker, et al.
Antiviral Research|March 1, 1995
Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroupsR W Buckheit, V Fliakas-Boltz, W D Decker, et al.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
Infectious Diseases (London, England)|October 23, 2015
Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussisClaudia Guevara, Chengxian Zhang, Jennifer A Gaddy, et al.
The Journal of Infectious Diseases|February 17, 2018
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration PatientsYinong Young-Xu, Robertus Van Aalst, Salaheddin M Mahmud, et al.
Vaccine|August 26, 1999
An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric AssociatesE P Rothstein, E L Anderson, M D Decker, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescentsGeorge K Siberry, Paige L Williams, Jorge Lujan-Zilbermann, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|October 2, 2007
Veterinary field test as screening tool for mastitis and HIV-1 viral load in breastmilk from HIV-infected Zambian womenStephanie M Dorosko, Donald M Thea, George Saperstein, et al.
Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Pediatrics|September 1, 1995
Comparison of 13 acellular pertussis vaccines: overview and serologic responseK M Edwards, B D Meade, M D Decker, et al.
Antiviral Research|March 1, 1995
Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroupsR W Buckheit, V Fliakas-Boltz, W D Decker, et al.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
Infectious Diseases (London, England)|October 23, 2015
Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussisClaudia Guevara, Chengxian Zhang, Jennifer A Gaddy, et al.
The Journal of Infectious Diseases|February 17, 2018
Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration PatientsYinong Young-Xu, Robertus Van Aalst, Salaheddin M Mahmud, et al.
Vaccine|August 26, 1999
An acellular pertussis vaccine in healthy adults: safety and immunogenicity. Pennridge Pediatric AssociatesE P Rothstein, E L Anderson, M D Decker, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescentsGeorge K Siberry, Paige L Williams, Jorge Lujan-Zilbermann, et al.
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|October 2, 2007
Veterinary field test as screening tool for mastitis and HIV-1 viral load in breastmilk from HIV-infected Zambian womenStephanie M Dorosko, Donald M Thea, George Saperstein, et al.
Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.
Pageof 29